|
Volumn 151, Issue 3, 2009, Pages 210-211
|
Modeling comparative effectiveness and the value of research
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 LYMPHOCYTE COUNT;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
EDITORIAL;
HEALTH CARE COST;
HEALTH CARE POLICY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN IMMUNODEFICIENCY VIRUS;
LIFE EXPECTANCY;
MATHEMATICAL MODEL;
POPULATION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RESEARCH;
SOUTH AFRICA;
SURVIVAL;
|
EID: 68249112608
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/0003-4819-151-3-200908040-00010 Document Type: Editorial |
Times cited : (7)
|
References (5)
|